Selected FXR Agonist PBC Studies: Conference Coverage of AASLD
CCO Infectious Disease Podcast - Un pódcast de Clinical Care Options
Categorías:
Listen as Kris V. Kowdley MD, FAASLD, FACP, FACG, discusses exciting new data from AASLD 2023 for people with PBC, including a study that evaluated real-world outcomes in patients treated with an FXR agonist as second-line therapy, lessons learned from PBC outcomes trials, and a late-breaking study of PBC treatment using an FXR agonist plus a fibrate.
